Follow the Idorsia Ltd stock price and the full insider trade history of the company, a listed equity based in Switzerland. Shares trade on the CH market, under the authority of SIX SER. Market capitalisation: €1.9bn. The latest transaction was filed on 14 August 2026 (Purchase). The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€12m
4 ops.
Buy Volume
€107,677
2 ops.
Sell Volume
31Σ signal
Buys €12m€107,677 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,053 of 28,985 companies
33.7
score / 100
Value
18
Quality
49
FCF yld-8.7%
Earn yld-5.8%
EV/EBITDA·
ROE·
Gross mgn91%
Net mgn-51%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 August 2026
Declarations6 total
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior management·Executives·(filed)
Idorsia Ltd is a Swiss biopharmaceutical company focused on the research and development of innovative treatments for central nervous system disorders and other conditions. It is listed on the Swiss Stock Exchange under the ticker IDIA.